Prisma hospital participating in clinical trial for new COVID-19 antiviral treatment

  • By cvbizz
  • April 22, 2020
  • 0


Share This Post!

GREENVILLE, SC (FOX Carolina) – Prisma Health said Wednesday one of their hospitals is participating in an international clinical study of the drug Remdesivir as a potential treatment for moderate and severe COVID-19 patients.

Prisma said Remdesivir is an antiviral medication developed by the U.S. biopharmaceutical company Gilead Sciences.


Read Full Post

Upstate News Headlines